AKT1 and type 2 diabetes mellitus: The activated form of Akt, phosphorylated Akt (p-Akt), may inhibit several proapoptotic factors including glycogen synthase kinase-3 beta (GSK3β) [72], which in turn mediates insulin resistance and human type 2 diabetes [73].